methemoglobinemia
Information, Symptoms, Treatments and Resources
Methemoglobinemia is a blood disorder in which the body cannot recycle hemoglobin after it is damaged. Hemoglobin is the oxygen-carrying molecule found in red blood cells. In some cases of methemoglobinemia, the hemoglobin is unable to carry oxygen effectively to body tissues.
Hemoglobin M disease; Erythrocyte reductase deficiency; Generalized reductase deficiency
Methemoglobinemia may be passed down through families (inherited), or it may result from exposure to certain drugs, chemicals, or foods (acquired).
There are two forms of inherited methemoglobinemia. The first form is an autosomal recessive condition, which means it is passed on by both parents who usually do not have the condition themselves. It occurs when there is a problem with an enzyme called cytochrome b5 reductase. There are two subtypes of autosomal recessive methemoglobinemia:
- Type 1, also called erythrocyte reductase deficiency, occurs when red blood cells lack the enzyme.
- Type 2, also called generalized reductase deficiency, occurs when the enzyme doesn't work anywhere in the body.
The second form of inherited methemoglobinemia, called hemoglobin M disease, is caused by defects in the hemoglobin molecule itself. It is an autosomal dominant condition. That means only one parent needs to pass you the abnormal gene in order for you to inherit the disease.
Acquired methemoglobinemia is more common than the inherited forms. It occurs after exposure to certain chemicals and drugs, including:
- Anesthetics such as benzocaine and Xylocaine
- Benzene
- Certain antibiotics (including dapsone and chloroquine)
- Nitrites (used as additives to prevent spoilage of meat)
The condition may also occur in infants who are fed too many vegetables containing nitrates (such as beets).
Symptoms of type 1 methemoglobinemia (erythrocyte reductase deficiency) include:
- Bluish coloring of the skin and mucous membranes
Symptoms of type 2 methemoglobinemia (generalized reductase deficiency) include:
- Developmental delay
- Failure to thrive
- Mental retardation
- Seizures
Symptoms of hemoglobin M disease include:
- Bluish coloring of the skin and mucous membranes
- Mild breakdown of red blood cells
Symptoms of acquired methemoglobinemia include:
- Bluish coloring of the skin and mucous membranes
- Headache
- Fatigue
- Shortness of breath
- Lack of energy
Methemoglobinemia can be diagnosed with a blood test.
A baby with this condition will have bluish skin color (cyanosis) at birth or shortly thereafter. Arterial blood gases and pulse oximetry results will be normal, making the condition challenging to diagnose.
A medicine called methylene blue is used to treat persons with severe methemoglobinemia. Note: Methylene blue may be dangerous in patients who have or may be at risk for a blood disease called G6PD deficiency, and should not be used. If you or your child have G6PD deficiency, always tell the health care provider before treatment is given.
Ascorbic acid may also be used to reduce the level of methemoglobin.
Alternative treatments include hyperbaric oxygen therapy and exchange transfusions.
In most cases of mild acquired methemoglobinemia, no treatment is required, other than avoiding the medicine or chemical that caused the problem. However, treatment (such as a transfusion) may be needed in severe cases.
Persons with Type 1 methemoglobinemia and hemoglobin M disease usually do well. Type 2 methemoglobinemia is much more serious, and usually causes death within the first few years of life.
Persons with acquired methemoglobinemia usually do very well once the drug, food, or chemical that caused the problem is avoided.
Call your health care provider if there is a family history of methemoglobinemia and you develop symptoms of this disorder.
Call your health care provider or emergency services immediately if there is severe shortness of breath.
Genetic counseling is recommended for couples with a family history of methemoglobinemia who are considering having children.
Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:2267-2280.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
